301075 多瑞医药
已收盘 05-15 15:00:00
资讯
新帖
简况
多瑞医药（301075）披露已回购股份减持结果暨股份变动公告，5月14日股价上涨5.97%
证券之星 · 05-14 22:22
多瑞医药（301075）披露已回购股份减持结果暨股份变动公告，5月14日股价上涨5.97%
股市必读：多瑞医药（301075）5月12日披露最新机构调研信息
证券之星 · 05-13
股市必读：多瑞医药（301075）5月12日披露最新机构调研信息
多瑞医药（301075）披露回购股份集中竞价减持进展公告，5月8日股价上涨4.21%
证券之星 · 05-08
多瑞医药（301075）披露回购股份集中竞价减持进展公告，5月8日股价上涨4.21%
每周股票复盘：多瑞医药（301075）股东户数增37.69%
证券之星 · 05-03
每周股票复盘：多瑞医药（301075）股东户数增37.69%
多瑞医药（301075）2026年一季报简析：亏损收窄，存货明显上升
证券之星 · 04-30
多瑞医药（301075）2026年一季报简析：亏损收窄，存货明显上升
图解多瑞医药一季报：第一季度单季净利润同比增长10.45%
证券之星 · 04-29
图解多瑞医药一季报：第一季度单季净利润同比增长10.45%
4月21日多瑞医药现1笔折价17.95%的大宗交易 合计成交528.51万元
证券之星 · 04-21
4月21日多瑞医药现1笔折价17.95%的大宗交易 合计成交528.51万元
多瑞医药：目前公司尚无该技术的应用
证券之星 · 04-21
多瑞医药：目前公司尚无该技术的应用
股市必读：4月8日多瑞医药现1笔折价21.06%的大宗交易 合计成交505万元
证券之星 · 04-09
股市必读：4月8日多瑞医药现1笔折价21.06%的大宗交易 合计成交505万元
多瑞医药（301075）披露2026年第一次临时股东会决议公告，4月7日股价下跌1.55%
证券之星 · 04-07
多瑞医药（301075）披露2026年第一次临时股东会决议公告，4月7日股价下跌1.55%
4月1日多瑞医药现1笔折价20.5%的大宗交易 合计成交550万元
证券之星 · 04-01
4月1日多瑞医药现1笔折价20.5%的大宗交易 合计成交550万元
股市必读：多瑞医药（301075）3月27日收盘跌12.64%，主力净流出2628.04万元
证券之星 · 03-30
股市必读：多瑞医药（301075）3月27日收盘跌12.64%，主力净流出2628.04万元
股市必读：3月26日多瑞医药现1笔折价14.63%的大宗交易 合计成交903万元
证券之星 · 03-27
股市必读：3月26日多瑞医药现1笔折价14.63%的大宗交易 合计成交903万元
3月24日多瑞医药现1笔折价24.37%的大宗交易 合计成交1416万元
证券之星 · 03-24
3月24日多瑞医药现1笔折价24.37%的大宗交易 合计成交1416万元
多瑞医药（301075）披露2026年第一次临时股东大会通知，3月17日股价上涨0.18%
证券之星 · 03-17
多瑞医药（301075）披露2026年第一次临时股东大会通知，3月17日股价上涨0.18%
多瑞医药（301075）披露持股5%以上股东部分股份解除质押公告，3月12日股价下跌3.24%
证券之星 · 03-12
多瑞医药（301075）披露持股5%以上股东部分股份解除质押公告，3月12日股价下跌3.24%
多瑞医药（301075）披露减持回购股份比例达到1%的进展公告，3月9日股价上涨7.95%
证券之星 · 03-09
多瑞医药（301075）披露减持回购股份比例达到1%的进展公告，3月9日股价上涨7.95%
多瑞医药（301075）披露回购股份集中竞价减持进展公告，3月2日股价上涨0.51%
证券之星 · 03-02
多瑞医药（301075）披露回购股份集中竞价减持进展公告，3月2日股价上涨0.51%
多瑞医药（301075）披露王庆太、曹晓兵要约收购股份完成过户公告，2月27日股价上涨16.22%
证券之星 · 02-27
多瑞医药（301075）披露王庆太、曹晓兵要约收购股份完成过户公告，2月27日股价上涨16.22%
多瑞医药最新公告：王庆太、曹晓兵要约收购期满股票复牌
证券之星 · 02-26
多瑞医药最新公告：王庆太、曹晓兵要约收购期满股票复牌
加载更多
公司概况
公司名称：
西藏多瑞医药股份有限公司
所属行业：
医药制造业
上市日期：
2021-09-29
主营业务：
西藏多瑞医药股份有限公司的主营业务是药品制剂及化学中间体、多肽原料药的研发、生产和销售。公司的主要产品是艾博韦泰原料药、中间体。
发行价格：
27.27
{"stockData":{"symbol":"301075","market":"SZ","secType":"STK","nameCN":"多瑞医药","latestPrice":83.71,"timestamp":1778828592000,"preClose":87.2,"halted":0,"volume":3066676,"delay":0,"changeRate":-0.04,"floatShares":80000000,"shares":80000000,"eps":-1.2568,"marketStatus":"已收盘","change":-3.49,"latestTime":"05-15 15:00:00","open":87,"high":88.25,"low":82.6,"amount":259000000,"amplitude":0.0648,"askPrice":83.85,"askSize":1,"bidPrice":83.71,"bidSize":130,"shortable":0,"etf":0,"ttmEps":-1.2568,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1779067800000},"marketStatusCode":5,"adr":0,"adjPreClose":87.2,"symbolType":"stock","openAndCloseTimeList":[[1778808600000,1778815800000],[1778821200000,1778828400000]],"highLimit":95.92,"lowLimit":78.48,"ibTradeSell":false,"ibTradeBuySell":false,"totalEquity":80000000,"isCdr":false,"pbRate":11.31,"roa":"--","roe":"--","epsLYR":-1.29,"committee":0.769674,"marketValue":6697000000,"turnoverRate":0.0383,"status":1,"floatMarketCap":6697000000},"requestUrl":"/m/hq/s/301075/","defaultTab":"news","newsList":[{"id":"2635745977","title":"多瑞医药（301075）披露已回购股份减持结果暨股份变动公告，5月14日股价上涨5.97%","url":"https://stock-news.laohu8.com/highlight/detail?id=2635745977","media":"证券之星","labels":["shareholding","buyback"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2635745977?lang=zh_cn&edition=full","pubTime":"2026-05-14 22:22","pubTimestamp":1778768536,"startTime":"0","endTime":"0","summary":"截至2026年5月14日收盘，多瑞医药报收于87.2元，较前一交易日上涨5.97%，最新总市值为69.76亿元。近日，西藏多瑞医药股份有限公司发布《关于已回购股份减持结果暨股份变动公告》。公告显示，公司于2025年12月19日审议通过减持已回购股份计划，拟通过集中竞价方式减持不超过1,044,500股，占总股本1.31%。减持期间为2026年1月14日至2026年7月13日。减持后回购专用账户持股为0。本次减持不影响公司控制权，所得资金用于补充流动资金。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026051400042981.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,buyback","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301075","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635824904","title":"股市必读：多瑞医药（301075）5月12日披露最新机构调研信息","url":"https://stock-news.laohu8.com/highlight/detail?id=2635824904","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2635824904?lang=zh_cn&edition=full","pubTime":"2026-05-13 01:32","pubTimestamp":1778607130,"startTime":"0","endTime":"0","summary":"截至2026年5月12日收盘，多瑞医药报收于80.39元，下跌4.43%，换手率5.41%，成交量4.33万手，成交额3.55亿元。2025年公司研发投入共计3,241.09万元，占营业收入比例达到21.02%，全部为费用化投入，未进行资本化处理，研发投入占比提升主要因营业收入下降所致。公司于2025年12月5日正式完成控股股东及实际控制人变更，原实际控制人为邓勇，变更后由王庆太、崔子浩、曹晓兵三人成为新的实际控制人，三人互为一致行动人。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026051300001739.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301075","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633390644","title":"多瑞医药（301075）披露回购股份集中竞价减持进展公告，5月8日股价上涨4.21%","url":"https://stock-news.laohu8.com/highlight/detail?id=2633390644","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2633390644?lang=zh_cn&edition=full","pubTime":"2026-05-08 17:33","pubTimestamp":1778232808,"startTime":"0","endTime":"0","summary":"截至2026年5月8日收盘，多瑞医药报收于84.93元，较前一交易日上涨4.21%，最新总市值为67.94亿元。近日，西藏多瑞医药股份有限公司披露《关于回购股份集中竞价减持的进展公告》。公告显示，公司于2025年12月19日审议通过《关于回购股份集中竞价减持计划的议案》，拟通过集中竞价方式减持已回购股份，数量不超过1,044,500股，占总股本1.31%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026050800031415.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","301075"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2632467771","title":"每周股票复盘：多瑞医药（301075）股东户数增37.69%","url":"https://stock-news.laohu8.com/highlight/detail?id=2632467771","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2632467771?lang=zh_cn&edition=full","pubTime":"2026-05-03 06:10","pubTimestamp":1777759824,"startTime":"0","endTime":"0","summary":"截至2026年4月30日收盘，多瑞医药报收于83.45元，较上周的79.16元上涨5.42%。股本股东变化股东户数变动截至2026年3月31日，多瑞医药股东户数为6865.0户，较12月31日增加1879.0户，增幅37.69%。公司公告汇总2026年一季度报告西藏多瑞医药股份有限公司2026年第一季度报告显示，报告期内营业收入为32,431,205.53元，较上年同期下降34.41%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026050300001456.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","301075"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2631785765","title":"多瑞医药（301075）2026年一季报简析：亏损收窄，存货明显上升","url":"https://stock-news.laohu8.com/highlight/detail?id=2631785765","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2631785765?lang=zh_cn&edition=full","pubTime":"2026-04-30 06:48","pubTimestamp":1777502927,"startTime":"0","endTime":"0","summary":"据证券之星公开数据整理，近期多瑞医药发布2026年一季报。本报告期多瑞医药存货明显上升，存货同比增幅达69.16%。其中，毛利率7.54%，同比减54.92%，净利率-58.63%，同比减27.61%，销售费用、管理费用、财务费用总计1843.6万元，三费占营收比56.85%，同比增7.08%，每股净资产7.71元，同比减6.67%，每股经营性现金流-0.46元，同比减128.64%，每股收益-0.18元，同比增10.0%证券之星价投圈财报分析工具显示：业务评价：去年的净利率为-85.88%，算上全部成本后，公司产品或服务的附加值不高。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026043000023308.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301075","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2631539125","title":"图解多瑞医药一季报：第一季度单季净利润同比增长10.45%","url":"https://stock-news.laohu8.com/highlight/detail?id=2631539125","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2631539125?lang=zh_cn&edition=full","pubTime":"2026-04-29 04:54","pubTimestamp":1777409652,"startTime":"0","endTime":"0","summary":"证券之星消息，多瑞医药2026年一季报显示，一季度公司主营收入3243.12万元，同比下降34.41%；归母净利润-1396.8万元，同比上升10.45%；扣非净利润-1444.7万元，同比上升15.06%；负债率50.21%，投资收益-26.39万元，财务费用335.11万元，毛利率7.54%。财报数据概要请见下图:以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026042900010696.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301075"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629983081","title":"4月21日多瑞医药现1笔折价17.95%的大宗交易 合计成交528.51万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2629983081","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2629983081?lang=zh_cn&edition=full","pubTime":"2026-04-21 17:08","pubTimestamp":1776762519,"startTime":"0","endTime":"0","summary":"证券之星消息，4月21日多瑞医药发生大宗交易，交易数据如下：大宗交易成交价格66.9元，相对当日收盘价折价17.95%，成交7.9万股，成交金额528.51万元，买方营业部为招商证券股份有限公司上海牡丹江路证券营业部，卖方营业部为国联民生证券股份有限公司北京分公司。近三个月该股共发生5笔大宗交易，合计成交6690.0手，折价成交5笔。截至2026年4月21日收盘，多瑞医药报收于81.54元，下跌0.07%，换手率3.56%，成交量2.85万手，成交额2.32亿元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026042100038307.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","301075"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629770172","title":"多瑞医药：目前公司尚无该技术的应用","url":"https://stock-news.laohu8.com/highlight/detail?id=2629770172","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2629770172?lang=zh_cn&edition=full","pubTime":"2026-04-21 08:51","pubTimestamp":1776732686,"startTime":"0","endTime":"0","summary":"证券之星消息，多瑞医药(301075)04月20日在投资者关系平台上答复投资者关心的问题。投资者提问：目前行业内在仲丁基锂连续流规模化生产上已出现明显技术领先企业，该技术直接决定高难度创新药分子的可开发性与商业化效率。请问公司是否掌握相关核心工艺？有无具体项目案例、产能规模及客户验证？若存在明显技术代差，将如何应对高端订单流失的风险？多瑞医药回复：尊敬的投资者您好，目前公司尚无该技术的应用。感谢您对公司的关注。以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026042100014164.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301075","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2626926212","title":"股市必读：4月8日多瑞医药现1笔折价21.06%的大宗交易 合计成交505万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2626926212","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2626926212?lang=zh_cn&edition=full","pubTime":"2026-04-09 01:24","pubTimestamp":1775669051,"startTime":"0","endTime":"0","summary":"截至2026年4月8日收盘，多瑞医药报收于63.97元，上涨2.6%，换手率1.58%，成交量1.26万手，成交额8051.61万元。当日关注点来自交易信息汇总：4月8日主力资金净流出475.03万元，显示主力短期看空情绪明显。来自交易信息汇总：同日发生一笔折价21.06%的大宗交易，合计成交505万元，折价幅度显著。大宗交易4月8日多瑞医药现1笔折价21.06%的大宗交易，合计成交505万元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026040900001119.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","301075"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2625931686","title":"多瑞医药（301075）披露2026年第一次临时股东会决议公告，4月7日股价下跌1.55%","url":"https://stock-news.laohu8.com/highlight/detail?id=2625931686","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2625931686?lang=zh_cn&edition=full","pubTime":"2026-04-07 18:05","pubTimestamp":1775556315,"startTime":"0","endTime":"0","summary":"截至2026年4月7日收盘，多瑞医药报收于62.35元，较前一交易日下跌1.55%，最新总市值为49.88亿元。该股当日开盘63.98元，最高63.98元，最低61.83元，成交额达7229.04万元，换手率为1.44%。公司于近日披露《2026年第一次临时股东会决议公告》。北京大成律师事务所对本次会议出具法律意见书，认为会议召集、召开程序合法合规，表决结果合法有效。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026040700025010.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301075","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2624596256","title":"4月1日多瑞医药现1笔折价20.5%的大宗交易 合计成交550万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2624596256","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2624596256?lang=zh_cn&edition=full","pubTime":"2026-04-01 17:02","pubTimestamp":1775034142,"startTime":"0","endTime":"0","summary":"证券之星消息，4月1日多瑞医药发生大宗交易，交易数据如下：大宗交易成交价格50元，相对当日收盘价折价20.5%，成交11万股，成交金额550万元，买方营业部为招商证券股份有限公司上海牡丹江路证券营业部，卖方营业部为国联民生证券股份有限公司北京分公司。近三个月该股共发生5笔大宗交易，合计成交6950.0手，折价成交3笔。截至2026年4月1日收盘，多瑞医药报收于62.89元，上涨1.11%，换手率2.11%，成交量1.68万手，成交额1.06亿元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026040100030578.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","301075"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2623357892","title":"股市必读：多瑞医药（301075）3月27日收盘跌12.64%，主力净流出2628.04万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2623357892","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2623357892?lang=zh_cn&edition=full","pubTime":"2026-03-30 01:49","pubTimestamp":1774806549,"startTime":"0","endTime":"0","summary":"截至2026年3月27日收盘，多瑞医药报收于66.0元，下跌12.64%，换手率7.24%，成交量5.79万手，成交额3.94亿元。当日关注点来自交易信息汇总：多瑞医药股价连续2日下跌，近5个交易日中3日跌幅超5%，主力资金前10日累计净流出超3153万元。来自交易信息汇总：3月27日多瑞医药收盘报66元，跌12.64%，主力资金单日净流出2628.04万元，散户资金净流入3365.94万元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026033000000397.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","301075"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2622845893","title":"股市必读：3月26日多瑞医药现1笔折价14.63%的大宗交易 合计成交903万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2622845893","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2622845893?lang=zh_cn&edition=full","pubTime":"2026-03-27 02:26","pubTimestamp":1774549571,"startTime":"0","endTime":"0","summary":"截至2026年3月26日收盘，多瑞医药报收于75.55元，下跌6.21%，换手率2.15%，成交量1.72万手，成交额1.32亿元。当日关注点来自交易信息汇总：3月26日主力资金净流入409.09万元，显示主力对多瑞医药的阶段性青睐。来自交易信息汇总：同日发生一笔折价14.63%的大宗交易，合计成交903万元，反映部分股东减持意愿较强。来自交易信息汇总：游资资金净流出3134.01万元，与散户资金流入形成明显反差。大宗交易3月26日多瑞医药现1笔折价14.63%的大宗交易，合计成交903万元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026032700004222.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301075","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2621050328","title":"3月24日多瑞医药现1笔折价24.37%的大宗交易 合计成交1416万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2621050328","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2621050328?lang=zh_cn&edition=full","pubTime":"2026-03-24 17:01","pubTimestamp":1774342902,"startTime":"0","endTime":"0","summary":"证券之星消息，3月24日多瑞医药发生大宗交易，交易数据如下：大宗交易成交价格59元，相对当日收盘价折价24.37%，成交24万股，成交金额1416万元，买方营业部为招商证券股份有限公司上海牡丹江路证券营业部，卖方营业部为国联民生证券股份有限公司北京分公司。近三个月该股共发生3笔大宗交易，合计成交4450.0手，折价成交1笔。截至2026年3月24日收盘，多瑞医药报收于78.01元，上涨5.79%，换手率1.41%，成交量1.13万手，成交额8668.47万元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026032400028038.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301075","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2620847520","title":"多瑞医药（301075）披露2026年第一次临时股东大会通知，3月17日股价上涨0.18%","url":"https://stock-news.laohu8.com/highlight/detail?id=2620847520","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2620847520?lang=zh_cn&edition=full","pubTime":"2026-03-17 22:58","pubTimestamp":1773759493,"startTime":"0","endTime":"0","summary":"截至2026年3月17日收盘，多瑞医药报收于82.91元，较前一交易日上涨0.18%，最新总市值为66.33亿元。该股当日开盘83.0元，最高83.98元，最低81.62元，成交额达9317.79万元，换手率为1.41%。近日，多瑞医药披露《关于召开2026年第一次临时股东会的通知》。股权登记日为2026年3月31日，股东可通过现场或网络投票方式参与表决。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026031700042437.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301075","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2618340130","title":"多瑞医药（301075）披露持股5%以上股东部分股份解除质押公告，3月12日股价下跌3.24%","url":"https://stock-news.laohu8.com/highlight/detail?id=2618340130","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2618340130?lang=zh_cn&edition=full","pubTime":"2026-03-12 22:19","pubTimestamp":1773325156,"startTime":"0","endTime":"0","summary":"截至2026年3月12日收盘，多瑞医药报收于87.39元，较前一交易日下跌3.24%，最新总市值为69.91亿元。该股当日开盘89.0元，最高89.5元，最低85.85元，成交额达1.82亿元，换手率为2.61%。多瑞医药于2026年3月12日披露《关于持股5%以上股东部分股份解除质押的公告》。本次解除质押股份合计4,194,408股，占公司总股本的5.24%。本次变动后，西藏嘉康累计质押股份为3,340,000股，占其所持股份的37.40%，占公司总股本的4.18%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026031200038758.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","301075"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2618622602","title":"多瑞医药（301075）披露减持回购股份比例达到1%的进展公告，3月9日股价上涨7.95%","url":"https://stock-news.laohu8.com/highlight/detail?id=2618622602","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2618622602?lang=zh_cn&edition=full","pubTime":"2026-03-09 22:28","pubTimestamp":1773066502,"startTime":"0","endTime":"0","summary":"截至2026年3月9日收盘，多瑞医药报收于90.52元，较前一交易日上涨7.95%，最新总市值为72.42亿元。该股当日开盘82.88元，最高91.39元，最低82.8元，成交额达2.51亿元，换手率为3.59%。公司于2026年3月9日发布《关于减持回购股份比例达到1%的进展公告》。公司已于2025年12月19日披露减持计划，拟减持数量不超过1,044,500股，减持期间为2026年1月14日至2026年7月13日。减持计划实施存在不确定性，公司将根据市场情况决定具体减持安排。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026030900035314.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301075","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2616535950","title":"多瑞医药（301075）披露回购股份集中竞价减持进展公告，3月2日股价上涨0.51%","url":"https://stock-news.laohu8.com/highlight/detail?id=2616535950","media":"证券之星","labels":["shareholding","buyback"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2616535950?lang=zh_cn&edition=full","pubTime":"2026-03-02 23:31","pubTimestamp":1772465471,"startTime":"0","endTime":"0","summary":"截至2026年3月2日收盘，多瑞医药报收于74.88元，较前一交易日上涨0.51%，最新总市值为59.9亿元。公司于近日披露《关于回购股份集中竞价减持的进展公告》。公告显示，西藏多瑞医药股份有限公司于2025年12月19日审议通过《关于回购股份集中竞价减持计划的议案》，拟通过集中竞价方式减持已回购股份，数量不超过1,044,500股，占总股本1.31%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026030200040647.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,buyback","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301075","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2614857128","title":"多瑞医药（301075）披露王庆太、曹晓兵要约收购股份完成过户公告，2月27日股价上涨16.22%","url":"https://stock-news.laohu8.com/highlight/detail?id=2614857128","media":"证券之星","labels":["shareholding","merge"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2614857128?lang=zh_cn&edition=full","pubTime":"2026-02-27 23:14","pubTimestamp":1772205256,"startTime":"0","endTime":"0","summary":"公司于2026年2月27日披露《关于王庆太、曹晓兵要约收购公司股份完成过户的公告》。公告显示，西藏多瑞医药股份有限公司于2026年1月21日披露要约收购报告书，王庆太、曹晓兵向除其一致行动人以外的全体股东发出部分要约，拟收购19,440,000股，占总股本24.30%，价格为32.07元/股，要约期限为2026年1月22日至2月24日。截至期限届满，王庆太获3户预受要约股份17,600,600股，曹晓兵获4户预受要约股份1,851,400股，其中西藏嘉康时代科技发展有限公司已预受要约19,440,000股。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026022700043158.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,merge","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","301075"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2614016580","title":"多瑞医药最新公告：王庆太、曹晓兵要约收购期满股票复牌","url":"https://stock-news.laohu8.com/highlight/detail?id=2614016580","media":"证券之星","labels":["merge"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2614016580?lang=zh_cn&edition=full","pubTime":"2026-02-26 17:12","pubTimestamp":1772097151,"startTime":"0","endTime":"0","summary":"多瑞医药(301075.SZ)公告称，王庆太、曹晓兵要约收购期限已届满，收购人及其一致行动人共计持有公司4312万股股份，占总股本的53.90%，公司股权分布仍符合上市条件。公司股票自2026年2月27日起复牌。以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026022600025747.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"merge","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","301075"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"ret":0,"serverTime":1778971494619,"stockEarnings":[{"period":"1week","weight":-0.0144},{"period":"1month","weight":0.2347},{"period":"3month","weight":0.3484},{"period":"6month","weight":0.5533},{"period":"1year","weight":2.4691},{"period":"ytd","weight":0.4029}],"compareEarnings":[{"period":"1week","weight":-0.0107},{"period":"1month","weight":0.0269},{"period":"3month","weight":0.0131},{"period":"6month","weight":0.0363},{"period":"1year","weight":0.2232},{"period":"ytd","weight":0.042}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"西藏多瑞医药股份有限公司","boardCode":"AI0027","boardName":"医药制造业","stockholders":"6865人(较上一季度增加37.69%)","perCapita":"11653股","listingDate":"2021-09-29","address":"西藏自治区昌都市卡若区经济技术开发区A区创业大道9号","registeredCapital":"8000万元","survey":" 西藏多瑞医药股份有限公司的主营业务是药品制剂及化学中间体、多肽原料药的研发、生产和销售。公司的主要产品是艾博韦泰原料药、中间体。","listedPrice":27.27},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.42.2","shortVersion":"4.42.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"多瑞医药(301075)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供多瑞医药(301075)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"多瑞医药,301075,多瑞医药股票,多瑞医药股票老虎,多瑞医药股票老虎国际,多瑞医药行情,多瑞医药股票行情,多瑞医药股价,多瑞医药股市,多瑞医药股票价格,多瑞医药股票交易,多瑞医药股票购买,多瑞医药股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"多瑞医药(301075)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供多瑞医药(301075)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}